Artemis Wealth Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

Artemis Wealth Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,137	Closed	-$1.42K	–	141
2022 Q1	$1.42K	Hold	1,137	–	–	﹤0.01%	57
2021 Q4	$1.32K	Hold	1,137	–	–	﹤0.01%	70
2021 Q3	$2.18K	Hold	1,137	–	–	﹤0.01%	75
2021 Q2	$2.66K	Hold	1,137	–	–	﹤0.01%	71
2021 Q1	$3.08K	Hold	1,137	–	–	﹤0.01%	72
2020 Q4	$2.75K	Hold	1,137	–	–	﹤0.01%	58
2020 Q3	$2.6K	Hold	1,137	–	–	﹤0.01%	76
2020 Q2	$2.62K	Hold	1,137	–	–	﹤0.01%	52
2020 Q1	$1.96K	Hold	1,137	–	–	﹤0.01%	58
2019 Q4	$2.35K	Hold	1,137	–	–	﹤0.01%	117
2019 Q3	$3.3K	Hold	1,137	–	–	﹤0.01%	26
2019 Q2	$4.46K	Hold	1,137	–	–	﹤0.01%	26
2019 Q1	$5.37K	Hold	1,137	–	–	﹤0.01%	26
2018 Q4	$2.61K	Hold	1,137	–	–	﹤0.01%	39
2018 Q3	$7.09K	Hold	1,137	–	–	﹤0.01%	26
2018 Q2	$7.78K	Hold	1,137	–	–	0.01%	26
2018 Q1	$9.55K	Hold	1,137	–	–	0.01%	27
2017 Q4	$10.5K	Hold	1,137	–	–	0.01%	25
2017 Q3	$13.3K	Hold	1,137	–	–	0.01%	23
2017 Q2	$47.5K	Hold	1,137	–	–	0.04%	11
2017 Q1	$55.4K	Hold	1,137	–	–	0.05%	10
2016 Q4	$37K	Buy	+1,137	New	+$37.4K	0.03%	6

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Artemis Wealth Advisors's GNCA Position: Q2 2022 in Review

Artemis Wealth Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 1,137 shares — an estimated $1.42K sold.

Artemis Wealth Advisors first reported a position in GNCA in Q4 2016 and held it in 22 quarters. The position peaked at $55.4K in Q1 2017. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Artemis Wealth Advisors reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Artemis Wealth Advisors sold 1,137 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $1.42K.
Artemis Wealth Advisors first reported a position in Genocea Biosciences, Inc. in Q4 2016 and held it in 22 quarters.
Artemis Wealth Advisors's Genocea Biosciences, Inc. position peaked at $55.4K in Q1 2017.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Artemis Wealth Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.